Calithera Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$18,866,000 over the previous period. Total operating expenses were $42,074,000.

Profit Margin

Calithera Biosciences, Inc. (NASDAQ:CALA): Profit margin
2013 0 -12.37M
2014 0 -21.71M
2015 0 -32.64M
2016 0 -38.00M
2017 25.95M -27.82M -107.21%
2018 22.25M -51.47M -231.29%
2019 0 -86.34M
2020 0 -88.52M
2021 9.75M -165.33M -1695.77%
2022 0 -18.86M

CALA Income Statement (2013 โ€“ 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
09.75M0022.25M25.95M0000
Cost of revenue
001.87M0000000
Gross profit
09.75M-1.87M022.25M25.95M0000
Operating exp.
Research and development
28.53M53.45M71.01M76.29M66.19M43.11M27.74M23.74M16.36M9.9M
Selling and marketing
0000000000
Total operating expenses
42.07M74.30M91.38M92.89M79.53M55.64M38.33M32.81M21.72M12.37M
Operating income
-42.07M-115.43M-91.38M-92.89M-57.28M-29.68M-38.33M-32.81M-21.72M-12.37M
Other income (expenses), net
2.42M345K1.25M3.03M2.65M1.86M330K175K9K1K
Income before tax
-39.65M-115.08M-90.13M-89.86M-54.62M-27.82M-38.00M-32.64M-21.71M-12.37M
Income tax expense
-20.78M50.25M-1.61M-3.51M-3.15M-365K-297K-404K-361K0
Net income
-18.86M-165.33M-88.52M-86.34M-51.47M-27.82M-38.00M-32.64M-21.71M-12.37M
Earnings per share
Basic EPS
-3.78-44.77-25.73-36.5-28.12-16.89-39.01-36.18-93.34-31.36
Diluted EPS
-3.78-44.77-25.73-36.5-28.12-16.89-39.01-36.18-93.34-31.36
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source